# NanoStealth NBA Translation Extension

## Overview

This document describes how NanoStealth extends TumorTrack's NBA Translation Framework to provide intuitive, sports-inspired metrics for nanocarrier delivery optimization.

## Conceptual Foundation

The NBA Translation Framework maps basketball analytics to oncology metrics. NanoStealth extends this framework by applying the same intuitive mapping to nanocarrier pharmacokinetics and formulation properties.

## NanoStealth NBA Metric Mappings

### 1. Trueness → 3P% (Three Point Percentage)

**NBA Definition**: Percentage of three-point attempts that are successful.

**NanoStealth Analog**: **Targeting Accuracy / Hit Rate**

- Measures how effectively nanocarriers reach tumor sites
- Analogous to "shooting accuracy" in basketball

**Formula**:
```python
trueness = (tumor_accumulation / total_dose) * specificity_factor
# Range: 0.0 to 1.0
```

**NBA-Style Presentation**:
```
Trueness: 72% (Good)
"This formulation has a 72% hit rate - like a good three-point shooter!"

Breakdown:
- Tumor accumulation: 36 mg (out of 50 mg dose)
- EPR effect coefficient: 1.2
- Non-specific binding: 8%
```

**Clinical Interpretation**:
- < 40%: Poor targeting (like a bad shooter)
- 40-60%: Average targeting (league average)
- 60-75%: Good targeting (above average player)
- > 75%: Excellent targeting (elite shooter)

### 2. Flow → AST% (Assist Percentage)

**NBA Definition**: Percentage of teammate field goals a player assists while on court.

**NanoStealth Analog**: **Circulation Efficiency / Distribution**

- Measures how well nanocarriers circulate and distribute throughout the body
- Analogous to "ball movement" and "assists" in basketball

**Formula**:
```python
flow = AUC_plasma / (dose * clearance_rate)
# Half-life in hours
```

**NBA-Style Presentation**:
```
Flow: 24.5 hours (Elite)
"This nanocarrier assists drug delivery like a point guard with high AST%!"

Breakdown:
- Plasma half-life: 24.5 hours
- RES uptake: 12% (low, good)
- Circulation persistence: Excellent
```

**Clinical Interpretation**:
- < 6 hours: Rapid clearance (low assist player)
- 6-12 hours: Moderate circulation (average)
- 12-24 hours: Extended circulation (high assist player)
- > 24 hours: Long circulation (elite playmaker)

### 3. Toxicity → TOV% (Turnover Percentage)

**NBA Definition**: Percentage of possessions ending in a turnover.

**NanoStealth Analog**: **Off-Target Accumulation / Safety Risk**

- Measures unwanted accumulation in clearance organs (liver, spleen, kidney)
- Analogous to "turnovers" or "mistakes" in basketball

**Formula**:
```python
toxicity = (liver_accumulation * 0.4) + (spleen_accumulation * 0.3) + (kidney_accumulation * 0.3)
# Range: 0.0 to 1.0
```

**NBA-Style Presentation**:
```
Toxicity: 18% (Acceptable)
"Low turnover rate - this formulation protects the ball (avoids off-target effects)!"

Breakdown:
- Liver burden: 12% of dose
- Spleen burden: 8% of dose
- Kidney burden: 6% of dose
- Weighted score: 0.18
```

**Clinical Interpretation**:
- < 15%: Excellent safety (low turnover player)
- 15-25%: Acceptable safety (average turnover rate)
- 25-35%: Moderate risk (high turnover player)
- > 35%: High risk (turnover-prone, needs refinement)

### 4. Durability → MP (Minutes Played)

**NBA Definition**: Average minutes per game (availability).

**NanoStealth Analog**: **Treatment Sustainability / Dose Cycles**

- Expected number of effective dosing cycles before formulation degradation or tolerance issues
- Analogous to "player availability" and "endurance"

**Formula**:
```python
durability = cycles_planned * (1 - failure_rate)
# Number of effective cycles
```

**NBA-Style Presentation**:
```
Durability: 11.2 cycles (High Endurance)
"This formulation stays in the game - like a workhorse with high MP!"

Breakdown:
- Planned cycles: 12
- Dropout risk: 7%
- Expected completions: 11.2
- Formulation stability: 95%
```

**Clinical Interpretation**:
- < 4 cycles: Limited durability (injury-prone player)
- 4-8 cycles: Standard course (average minutes)
- 8-12 cycles: Extended therapy (high minutes player)
- > 12 cycles: Very durable (iron man status)

### 5. Cooperation Index → Team AST/FG Ratio

**NBA Definition**: Team assists per field goal made.

**NanoStealth Analog**: **Multi-Component Synergy**

- How well different nanocarrier components work together (polymer, drug, targeting ligand)
- Analogous to "team chemistry" and "ball movement"

**Formula**:
```python
cooperation_index = synergy_factor * (1 + optimization_boost)
# Range: 0.0 to 1.0
```

**NBA-Style Presentation**:
```
Cooperation: 0.78 (Excellent Team Play)
"Components work together like a high-assist team!"

Breakdown:
- Polymer-drug compatibility: 0.85
- Surface modification synergy: 0.72
- Targeting ligand efficiency: 0.77
- Overall cooperation: 0.78
```

**Clinical Interpretation**:
- < 0.50: Poor synergy (iso-heavy team)
- 0.50-0.65: Moderate synergy (average team play)
- 0.65-0.80: Good synergy (ball movement team)
- > 0.80: Excellent synergy (Warriors-level passing)

### 6. Tempo → PACE (Possessions Per 48 Minutes)

**NBA Definition**: Number of possessions per 48 minutes.

**NanoStealth Analog**: **Dosing Frequency**

- Days between doses (inverse of tempo - slower pace = longer interval)
- Analogous to "game pace" in basketball

**Formula**:
```python
tempo = dosing_interval_days
# Days between doses
```

**NBA-Style Presentation**:
```
Tempo: 7 days (Moderate Pace)
"Weekly dosing - like a balanced-pace offense!"

Breakdown:
- Dosing interval: 7 days
- Formulation half-life: 24 hours
- Accumulation risk: Low
- Patient convenience: Good
```

**Clinical Interpretation**:
- 1-3 days: Fast tempo (run-and-gun)
- 4-7 days: Moderate tempo (balanced)
- 7-14 days: Slow tempo (half-court offense)
- > 14 days: Very slow (deliberate pace)

## Integration with TumorTrack NBA Translation

### Unified Dashboard

NanoStealth metrics appear alongside tumor treatment metrics in the TumorTrack interface:

```
=================================================
PROTOCOL: PLGA-PEG Doxorubicin Nanoparticles
=================================================

Nanocarrier Performance (NBA Style):
-------------------------------------
3P%  (Trueness):    72%    ████████████░░░░░  Elite
AST% (Flow):        24.5h  ████████████████░  Elite  
TOV% (Toxicity):    18%    ██████████████░░░  Good
MP   (Durability):  11.2   ████████████████░  High
COOP (Synergy):     0.78   ████████████████░  Excellent
PACE (Tempo):       7d     ████████░░░░░░░░░  Moderate

Treatment Efficacy:
-------------------
pCR Rate:           68%    ████████████████░  Excellent
Net Benefit:        +42    ████████████████░  Strong
Resistance Risk:    12%    ██████░░░░░░░░░░░  Low

Combined Score: 87/100 (Highly Recommended)
```

### Cross-Translation Examples

#### Example 1: High-Risk, High-Reward Formulation

```
Nanocarrier: Aggressive Lipid Nanoparticle

NBA Translation:
- 3P% (Trueness): 82% (Like Steph Curry - elite shooting)
- TOV% (Toxicity): 28% (Like Russell Westbrook - high turnovers)
- Net Rating: +15 (Still positive despite turnovers)

Clinical Interpretation:
"This is your 'high-volume shooter' - great targeting but watch for toxicity.
Like a star player who scores a lot but also turns it over - the benefits 
outweigh the risks, but monitor closely."
```

#### Example 2: Balanced, Reliable Formulation

```
Nanocarrier: Standard PLGA Nanoparticle

NBA Translation:
- 3P% (Trueness): 58% (Like Klay Thompson - consistent)
- AST% (Flow): 18h (Good distribution)
- TOV% (Toxicity): 14% (Low mistakes)
- MP (Durability): 10 cycles (Reliable)

Clinical Interpretation:
"This is your 'two-way player' - doesn't excel in any one area but 
does everything well. Reliable, balanced, and sustainable."
```

#### Example 3: Long-Circulating Stealth Formulation

```
Nanocarrier: PEGylated Liposome

NBA Translation:
- AST% (Flow): 36h (Like Chris Paul - all-time great facilitator)
- COOP (Synergy): 0.85 (Excellent team chemistry)
- TOV% (Toxicity): 9% (Elite ball security)
- 3P% (Trueness): 64% (Above average shooting)

Clinical Interpretation:
"This is your 'floor general' - orchestrates drug delivery efficiently,
rarely makes mistakes, and gets teammates (components) involved.
Long circulation time means sustained effect."
```

## NBA-Style Comparison Tables

### Formulation Leaderboard

```
Rank  Formulation                3P%   AST%   TOV%   MP    Overall
====  ========================  ====  =====  =====  ====  =======
1.    PEG-PLGA-Dox (Elite)      72%   24.5h   18%   11.2   87/100
2.    Liposomal-PTX (All-Star)  68%   28.0h   12%   10.8   85/100
3.    Lipid NP-MTX (Starter)    61%   20.0h   15%   9.5    79/100
4.    Polymer Mic-GEM (Sixth)   58%   16.5h   19%   8.2    74/100
5.    Plain PLGA-DOX (Bench)    52%   14.0h   22%   7.1    68/100
```

### Head-to-Head Matchup

```
PLGA-PEG vs. Liposomal
======================

Category         PLGA-PEG  Liposomal  Winner
--------         --------  ---------  ------
Trueness (3P%)   72%       68%        PLGA-PEG
Flow (AST%)      24.5h     28.0h      Liposomal
Toxicity (TOV%)  18%       12%        Liposomal (lower is better)
Durability (MP)  11.2      10.8       PLGA-PEG

Final Score:     87        85         PLGA-PEG (close matchup!)

Analysis: "Both are championship-caliber formulations. PLGA-PEG has 
slightly better targeting and durability, while Liposomal has superior 
circulation and safety. Choose PLGA-PEG for aggressive tumor targeting,
Liposomal for maximum safety."
```

## Visualization in UI

### NBA-Style Stat Cards

Each nanocarrier formulation gets an NBA-style "player card":

```
┌─────────────────────────────────────┐
│  PLGA-PEG Doxorubicin              │
│  #1 Point Guard - Elite Tier       │
├─────────────────────────────────────┤
│  Season Stats (YTD):                │
│  • Trueness (3P%):   72%    ⭐⭐⭐⭐  │
│  • Flow (AST%):      24.5h  ⭐⭐⭐⭐⭐│
│  • Toxicity (TOV%):  18%    ⭐⭐⭐⭐  │
│  • Durability (MP):  11.2   ⭐⭐⭐⭐⭐│
├─────────────────────────────────────┤
│  Advanced Analytics:                │
│  • PER (Formula Efficiency): 24.8   │
│  • Win Shares: 8.2                  │
│  • True Shooting %: 68%             │
├─────────────────────────────────────┤
│  Scouting Report:                   │
│  "Elite all-around performer. High  │
│   targeting accuracy with excellent │
│   circulation. Safe and durable.    │
│   MVP candidate for solid tumors."  │
└─────────────────────────────────────┘
```

## Clinician Communication

### Example Consultation Note

```
Dr. Johnson,

I ran the NanoStealth optimization for Mrs. Smith's case. Here's what I found:

The PLGA-PEG formulation is shooting 72% from downtown (excellent tumor 
targeting), with a 24-hour half-life (elite circulation like a great point 
guard). Toxicity is at 18% - about average, nothing concerning. We expect 
11 effective treatment cycles (high durability - this player can log minutes).

The liposomal alternative shoots 68% (still good) but has a longer half-life 
(28 hours) and lower toxicity (12% - elite ball security). It's like choosing
between a volume scorer vs. an efficient role player.

For Mrs. Smith's case, I'd go with the PLGA-PEG - the extra targeting accuracy
(+4%) is worth the slight increase in toxicity for her aggressive tumor.

Let me know if you want to see the full scouting report!

Best,
NanoStealth AI
```

## References

1. TumorTrack NBA Translation Framework: `docs/NBA_TRANSLATION.md`
2. NanoStealth Architecture: `docs/NANOSTEALTH.md`
3. Configuration: `config/nanostealth.json`

---

**Version**: 1.0.0  
**Last Updated**: 2025-12-18
